Navigation Links
A splice of the action: Translational role for WT1 isoform

In the June 15th issue of G&D, Dr. Marie-Louise Hammarskjold (UVA) and colleagues lend new insight into the function of the Wilms' Tumor 1 tumor suppressor. The Wilms' Tumor 1 (WT1) protein is important to both normal and pathological human development, with known roles in kidney and urogenital formation as well as several human cancers.

Dr. Hammarskjold and colleagues reveal that WT1 works not only at the transcriptional level, but also at the post-transcriptional level to regulate gene expression. The WT1 gene encodes two major alternatively spliced protein isoforms: WT1(+KTS) and WT1(-KTS). While WT1(-KTS) has an established role as a DNA-binding transcription factor, the function of WT1(+KTS) has been elusive.

Dr. Hammarskjold's team now show that WT1(+KTS) promotes translation of target mRNAs by aiding in the transport and cytoplasmic stability of unspliced, intron-containing mRNA. Dr. Hammarskjold explains that "the general impact of this study is that it highlights the links that exist between transcription and post-transcriptional gene regulation and the importance of alternative splicing. We hope that these results will stimulate further studies to identify genes that are regulated by WT1 at the translational level and the role that this type of regulation plays in normal development and disease."


'"/>

Source:Cold Spring Harbor Laboratory


Page: 1

Related biology news :

1. Products containing specific probes for detecting alternative splice forms protected
2. Gut reaction: Researchers define the colons genome
3. Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
(Date:2/14/2017)... 2017  Wake Forest Baptist Medical Center today announced Julie ... executive officer (CEO). Freischlag joins the medical center on ... , M.D., who last year announced that he would ... after leading it since 2008.   As ... Forest Baptist,s academic health system, which includes Wake Forest ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... Cousins Properties (NYSE: CUZ ) announced today that ... a 10-year, approximately 125,000 square-foot lease at Corporate Center, a ... Westshore submarket of Tampa, FL. ... Center for their new location in Tampa ... officer of Cousins Properties. "Amgen is a cutting-edge global company ...
(Date:3/27/2017)... ROCKVILLE, Md. , March 27, 2017 /PRNewswire/ ... $108.5 billion for 2016, according to a new ... patients, medical lab testing is performed to evaluate ... determine individual therapy, among other reasons.  The healthcare ... Services Market , provides an overview of ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... PMG ... Trial Collaborations (CTC) conference presented by The Conference Forum in Boston on April ... they collaborate to drive improved clinical trial outcomes and bring them closer to the ...
(Date:3/27/2017)... Israel , March 27, 2017 DarioHealth ... with mobile health and big data solutions, today announced ... party insurance coverage option for U.S. consumers who want ... DarioHealth has signed strategic alliance agreements with ... verify insurance coverage benefits, and if approved, will supply ...
Breaking Biology Technology: